Page 12 - Hematology_ Basic Principles and Practice ( PDFDrive )
P. 12

Contributors    ix


            Paolo F. Caimi, MD                                    John P. Chute, MD
            Seidman Cancer Center, Division of Hematology and Oncology,   Professor of Medicine and Radiation Oncology, Division of
            Case Comprehensive Cancer Center, University Hospitals, Case   Hematology/Oncology, Broad Stem Cell Research Center,
            Medical Center, Cleveland, Ohio                       University of California, Los Angeles, Los Angeles, California
            Pharmacology and Molecular Mechanisms of Antineoplastic Agents for   Hematopoietic Stem Cell Biology
            Hematologic Malignancies
                                                                  David B. Clark, PhD
            Michael A. Caligiuri, MD                              President, Platte Canyon Consulting, Inc., Shawnee, Colorado;
            JL Marakas Nationwide Insurance Enterprise Foundation Chair   Chairman, The Coalition for Hemophilia B, New York, New York
            of Cancer Research, Director, Comprehensive Cancer Center,   Preparation of Plasma-Derived and Recombinant Human Plasma
            Department of Internal Medicine, Division of Hematology, The   Proteins
            Ohio State University Comprehensive Cancer Center, Columbus,
            Ohio                                                  Thomas D. Coates, MD
            Natural Killer Cell Immunity                          Professor of Pediatrics and Pathology, University of Southern
                                                                  California Keck School of Medicine; Division Head for
            Michelle Canavan, MB, PhD                             Hematology, Children’s Center for Cancer and Blood Diseases,
            Specialist Registrar in Geriatric Medicine, University Hospital   Children’s Hospital Los Angeles, Los Angeles, California
            Limerick, Limerick, Ireland                           Disorders of Phagocyte Function
            Stroke
                                                                  Christopher R. Cogle, MD
            Alan B. Cantor, MD, PhD                               Professor of Medicine, Hematology-Oncology, University of
            Associate Professor of Pediatrics, Division of Pediatric Hematology/  Florida, Gainesville, Florida
            Oncology, Boston Children’s Hospital and Dana-Farber Cancer   Regulation of Gene Expression, Transcription, Splicing and RNA
            Institute, Harvard Medical School, Boston, Massachusetts  Metabolism
            Thrombocytopoiesis
                                                                  Nathan T. Connell, MD, MPH
            Manuel Carcao, MD, MSc                                Instructor in Medicine, Harvard Medical School, Hematology
            Hematologist, Division of Haematology/Oncology; Department   Division, Brigham and Women’s Hospital, Boston, Massachusetts
            of Paediatrics, Senior Associate Scientist, Child Health Evaluative   The Spleen and Its Disorders
            Sciences, Research Institute; The Hospital for Sick Children,
            Associate Professor of Pediatrics, University of Toronto, Toronto,   Elizabeth Cooke, RN, MN, AOCN, PMHNP-BC
            Ontario, Canada                                       Nurse Practitioner, City of Hope National Medical Center, Duarte,
            Hemophilia A and B                                    California
                                                                  Psychosocial Aspects of Hematologic Disorders
            Michael C. Carroll, PhD
            Professor of Pediatrics, Harvard Medical School; Senior Investigator,   Sarah Cooley, MD
            Program in Cellular and Molecular Medicine, Boston Children’s   Associate Professor of Medicine, Department of Medicine, Division
            Hospital, Boston, Massachusetts                       of Hematology, Oncology, and Transplantation, University of
            Complement and Immunoglobulin Biology Leading to Clinical   Minnesota; Associate Director, Cancer Experimental Therapeutics
            Translation                                           Initiative, Masonic Cancer Center, Minneapolis, Minnesota
                                                                  Natural Killer Cell-Based Therapies
            Shannon A. Carty, MD
            Assistant Professor, Division of Hematology/Oncology, Department   Paolo Corradini, MD
            of Medicine, University of Michigan, Ann Arbor, Michigan  Professor of Hematology; Chairman, Department of Oncology and
            T-Cell Immunity                                       Hemato-oncology, University of Milano, Milan, Italy
                                                                  T-Cell Lymphomas
            Jorge J. Castillo, MD
            Physician, Hematologic Malignancies, Dana-Farber Cancer   Mark A. Creager, MD
            Institute; Assistant Professor, Harvard Medical School, Boston,   Director, Heart and Vascular Center, Dartmouth-Hitchcock
            Massachusetts                                         Medical Center, Anna Gundlach Huber Professor of Medicine,
            Waldenström Macroglobulinemia/Lymphoplasmacytic Lymphoma  Geisel School of Medicine at Dartmouth, Lebanon, New
                                                                  Hampshire
            Anthony K.C. Chan, MBBS, FRCPC, FRCPath               Peripheral Artery Disease
            Professor of Pediatrics, McMaster University, Hamilton, Ontario,
            Canada                                                Richard J. Creger, PharmD
            Disorders of Coagulation in the Neonate               Clinical Associate Professor of Medicine, Case Western Reserve
                                                                  University School of Medicine, Cleveland, Ohio
            John Chapin, MD                                       Pharmacology and Molecular Mechanisms of Antineoplastic Agents for
            Assistant Professor of Medicine, Weill Cornell Medicine; Assistant   Hematologic Malignancies
            Attending Physician, Hematologic Oncology, NewYork-Presbyterian
            Hospital, New York, New York                          Caroline Cromwell, MD
            Thalassemia Syndromes                                 Assistant Professor of Hematology/Oncology, Mount Sinai
                                                                  Hospital, New York, New York
            April Chiu, MD                                        Hematologic Changes in Pregnancy
            Associate Attending, Memorial Sloan Kettering Cancer Center,
            Hematopathology Service, Departments of Pathology and   Mark A. Crowther, MD, MSc, FRCPC
            Laboratory Medicine, New York, New York               Professor of Medicine and Pathology and Molecular Medicine,
            Hodgkin Lymphoma: Clinical Manifestations, Staging, and Therapy  Medicine, McMaster University, Hamilton, Ontario, Canada
                                                                  Hematologic Manifestations of Renal Disease
   7   8   9   10   11   12   13   14   15   16   17